Why the study?
Tricuspid valve diseases have poor medical prognoses and carry significant morbidity and mortality with traditional surgery, while minimal access surgery may mitigate some surgical risks.
Does minimal access tricuspid valve surgery improve outcomes compared to standard sternotomy in patients with isolated tricuspid valve disease?
Does minimal access tricuspid valve surgery improve outcomes compared to standard sternotomy in patients with isolated tricuspid valve disease?
Minimal access tricuspid valve surgery offers a potentially safer alternative to standard sternotomy for isolated tricuspid valve disease, potentially reducing morbidity and hospital stay.
Answers are grounded in this paper and cite their sources.
May benefit select tricuspid patients; leaves open need for RCTs to confirm outcomes.
Tricuspid valve diseases are a heterogeneous group of pathologies that typically have poor prognoses when treated medically and are associated with significant morbidity and mortality with traditional surgical techniques. Minimal access tricuspid valve surgery may mitigate some of the surgical risks associated with the standard sternotomy approach by limiting pain, reducing blood loss, lowering the risk of wound infections, and shortening hospital stays. In certain patient populations, this may allow for a prompt intervention that could limit the pathologic effects of these diseases. Herein, we review the literature on minimal access tricuspid valve surgery focusing on perioperative planning, technique, and outcomes of minimal access endoscopic and robotic surgery for isolated tricuspid valve disease.
No takes yet. Share an insight, caveat, or question.
Sauvé et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: